Emil Peter Thrane Hertz

Emil Peter Thrane Hertz, Novo Nordisk Foundation Centre for Protein Research, University of Copenhagen, has been awarded a postdoc research grant from Lundbeck Foundation worth DKK 1,800,000.

His project will use an advanced version of the CRISPR gene-editing technology (‘the gene scissor) to study, among other things, disease mechanisms associated with the neurodegenerative disorder ALS.

Part of this project will be conducted in the USA at the Broad Institute, which is part of Harvard and the Massachusetts Institute of Technology (MIT).